Literature DB >> 19675183

Regulation of rat intestinal Na-dependent phosphate transporters by dietary phosphate.

Hector Giral1, Yupanqui Caldas, Eileen Sutherland, Paul Wilson, Sophia Breusegem, Nicholas Barry, Judith Blaine, Tao Jiang, Xiaoxin X Wang, Moshe Levi.   

Abstract

Hyperphosphatemia associated with chronic kidney disease is one of the factors that can promote vascular calcification, and intestinal P(i) absorption is one of the pharmacological targets that prevents it. The type II Na-P(i) cotransporter NaPi-2b is the major transporter that mediates P(i) reabsorption in the intestine. The potential role and regulation of other Na-P(i) transporters remain unknown. We have identified expression of the type III Na-P(i) cotransporter PiT-1 in the apical membrane of enterocytes. Na-P(i) transport activity and NaPi-2b and PiT-1 proteins are mostly expressed in the duodenum and jejunum of rat small intestine; their expression is negligible in the ileum. In response to a chronic low-P(i) diet, there is an adaptive response restricted to the jejunum, with increased brush border membrane (BBM) Na-P(i) transport activity and NaPi-2b, but not PiT-1, protein and mRNA abundance. However, in rats acutely switched from a low- to a high-P(i) diet, there is an increase in BBM Na-P(i) transport activity in the duodenum that is associated with an increase in BBM NaPi-2b protein abundance. Acute adaptive upregulation is restricted to the duodenum and induces an increase in serum P(i) that produces a transient postprandial hyperphosphatemia. Our study, therefore, indicates that Na-P(i) transport activity and NaPi-2b protein expression are differentially regulated in the duodenum vs. the jejunum and that postprandial upregulation of NaPi-2b could be a potential target for treatment of hyperphosphatemia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19675183      PMCID: PMC2781338          DOI: 10.1152/ajprenal.00279.2009

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  32 in total

1.  The role of an intracellular cysteine stretch in the sorting of the type II Na/phosphate cotransporter.

Authors:  Gavin S McHaffie; Chris Graham; Beate Kohl; Ursula Strunck-Warnecke; Andreas Werner
Journal:  Biochim Biophys Acta       Date:  2007-05-23

2.  Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men.

Authors:  Y Nishida; Y Taketani; H Yamanaka-Okumura; F Imamura; A Taniguchi; T Sato; E Shuto; K Nashiki; H Arai; H Yamamoto; E Takeda
Journal:  Kidney Int       Date:  2006-10-25       Impact factor: 10.612

3.  NaPi-mediated transcellular permeation is the dominant route in intestinal inorganic phosphate absorption in rats.

Authors:  Nobuaki Eto; Mikio Tomita; Masahiro Hayashi
Journal:  Drug Metab Pharmacokinet       Date:  2006-06       Impact factor: 3.614

4.  Relationship of phosphorus and calcium-phosphorus product with mortality in CKD.

Authors:  Vandana Menon; Tom Greene; Arema A Pereira; Xuelei Wang; Gerald J Beck; John W Kusek; Alan J Collins; Andrew S Levey; Mark J Sarnak
Journal:  Am J Kidney Dis       Date:  2005-09       Impact factor: 8.860

5.  Characterization of phosphate transport in rat vascular smooth muscle cells: implications for vascular calcification.

Authors:  Ricardo Villa-Bellosta; Yolanda E Bogaert; Moshe Levi; Víctor Sorribas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-02-22       Impact factor: 8.311

6.  Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibroblast growth factor 23.

Authors:  Ken-ichi Miyamoto; Mikiko Ito; Masashi Kuwahata; Shigeaki Kato; Hiroko Segawa
Journal:  Ther Apher Dial       Date:  2005-08       Impact factor: 1.762

7.  Deciphering PiT transport kinetics and substrate specificity using electrophysiology and flux measurements.

Authors:  Silvia Ravera; Leila V Virkki; Heini Murer; Ian C Forster
Journal:  Am J Physiol Cell Physiol       Date:  2007-05-09       Impact factor: 4.249

8.  Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD.

Authors:  Tamara Isakova; Orlando Gutierrez; Anand Shah; Lorraine Castaldo; Julie Holmes; Hang Lee; Myles Wolf
Journal:  J Am Soc Nephrol       Date:  2008-01-23       Impact factor: 10.121

Review 9.  Hyperphosphatemia in dialysis patients: the therapeutic role of lanthanum carbonate.

Authors:  M Cozzolino; D Brancaccio
Journal:  Int J Artif Organs       Date:  2007-04       Impact factor: 1.595

Review 10.  Phosphate metabolism in the setting of chronic kidney disease: significance and recommendations for treatment.

Authors:  Bryan Kestenbaum
Journal:  Semin Dial       Date:  2007 Jul-Aug       Impact factor: 3.455

View more
  49 in total

Review 1.  Hereditary disorders of renal phosphate wasting.

Authors:  Amir S Alizadeh Naderi; Robert F Reilly
Journal:  Nat Rev Nephrol       Date:  2010-10-05       Impact factor: 28.314

Review 2.  Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases.

Authors:  Fayez K Ghishan; Pawel R Kiela
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-11-18       Impact factor: 4.052

Review 3.  Dietary Phosphorus Intake and the Kidney.

Authors:  Alex R Chang; Cheryl Anderson
Journal:  Annu Rev Nutr       Date:  2017-06-14       Impact factor: 11.848

4.  Intestinal phosphate absorption: The paracellular pathway predominates?

Authors:  Matthew Saurette; R Todd Alexander
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-14

5.  Npt2b deletion attenuates hyperphosphatemia associated with CKD.

Authors:  Susan C Schiavi; Wen Tang; Christina Bracken; Stephen P O'Brien; Wenping Song; Joseph Boulanger; Susan Ryan; Lucy Phillips; Shiguang Liu; Cynthia Arbeeny; Steven Ledbetter; Yves Sabbagh
Journal:  J Am Soc Nephrol       Date:  2012-08-02       Impact factor: 10.121

Review 6.  Renal and extrarenal actions of Klotho.

Authors:  Ming Chang Hu; Makoto Kuro-o; Orson W Moe
Journal:  Semin Nephrol       Date:  2013-03       Impact factor: 5.299

7.  Liver X receptor-activating ligands modulate renal and intestinal sodium-phosphate transporters.

Authors:  Yupanqui A Caldas; Hector Giral; Michael A Cortázar; Eileen Sutherland; Kayo Okamura; Judith Blaine; Victor Sorribas; Hermann Koepsell; Moshe Levi
Journal:  Kidney Int       Date:  2011-06-15       Impact factor: 10.612

8.  NHE3 regulatory factor 1 (NHERF1) modulates intestinal sodium-dependent phosphate transporter (NaPi-2b) expression in apical microvilli.

Authors:  Hector Giral; DeeAnn Cranston; Luca Lanzano; Yupanqui Caldas; Eileen Sutherland; Joanna Rachelson; Evgenia Dobrinskikh; Edward J Weinman; R Brian Doctor; Enrico Gratton; Moshe Levi
Journal:  J Biol Chem       Date:  2012-08-17       Impact factor: 5.157

9.  Restoration of cytoskeletal and membrane tethering defects but not defects in membrane trafficking in the intestinal brush border of mice lacking both myosin Ia and myosin VI.

Authors:  Peter S Hegan; Dmitri V Kravtsov; Christina Caputo; Marie E Egan; Nadia A Ameen; Mark S Mooseker
Journal:  Cytoskeleton (Hoboken)       Date:  2015-09-16

10.  Effect of variations in dietary Pi intake on intestinal Pi transporters (NaPi-IIb, PiT-1, and PiT-2) and phosphate-regulating factors (PTH, FGF-23, and MEPE).

Authors:  Tatiana Martins Aniteli; Flávia Ramos de Siqueira; Luciene Machado Dos Reis; Wagner Vasques Dominguez; Elizabeth Maria Costa de Oliveira; Patrícia Castelucci; Rosa Maria Affonso Moysés; Vanda Jorgetti
Journal:  Pflugers Arch       Date:  2018-01-25       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.